1997
DOI: 10.2337/diab.46.11.1888
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of HLA-B Allele on the IDDM Risk Defined by DRB1*04 Subtypes and DQB1*0302

Abstract: The genes encoding the HLA-DQ heterodimer molecules, DQB1 and DQA1, have been found to have the strongest association with IDDM risk, although there is cumulative evidence for the effect of other gene loci within the major histocompatibility complex gene region. After the HLA-DQ locus, the HLA-DR locus has been suggested most often as contributing to the disease susceptibility. In this study we analyzed at the population level the effect of DR4 subtypes and class I, HLA-B alleles, on IDDM risk when the influen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
17
0

Year Published

1999
1999
2010
2010

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 55 publications
(20 citation statements)
references
References 16 publications
(16 reference statements)
3
17
0
Order By: Relevance
“…The major finding in our study—the strong effect of B*39 on the progression from β-cell autoimmunity to clinical disease—was only seen in subjects carrying the combination of both major class II risk haplotypes, the DR3/DR4 genotype. We have earlier observed HLA-B*39 to be common in type 1 diabetes–associated DRB1*0404 haplotypes in Finland (5), and we have also been able to demonstrate its predisposing effect on type 1 diabetes risk in DRB1*0404-DQB1*0302–positive subjects in Estonia and Russia (18). The presence of the HLA-B*39 allele in the DRB1*08-DQB1*0402 haplotype has also been found to be a risk factor for type 1 diabetes (3).…”
Section: Discussionsupporting
confidence: 59%
“…The major finding in our study—the strong effect of B*39 on the progression from β-cell autoimmunity to clinical disease—was only seen in subjects carrying the combination of both major class II risk haplotypes, the DR3/DR4 genotype. We have earlier observed HLA-B*39 to be common in type 1 diabetes–associated DRB1*0404 haplotypes in Finland (5), and we have also been able to demonstrate its predisposing effect on type 1 diabetes risk in DRB1*0404-DQB1*0302–positive subjects in Estonia and Russia (18). The presence of the HLA-B*39 allele in the DRB1*08-DQB1*0402 haplotype has also been found to be a risk factor for type 1 diabetes (3).…”
Section: Discussionsupporting
confidence: 59%
“…DRB1*0405 was shown to be the strongest DR4 subtype conferring risk for Type 1 diabetes in several populations including African-Americans and Mexican-Americans, Caucasian French and Sardinians [29], while it was not present in the Finnish population [13]. Such differences mostly mirror the prevalence of risk alleles in the background populations, but may also re¯ect haplotypic associations and/or yet uncharacterized susceptibility genes within the HLA gene region [16,30]. Such differences mostly mirror the prevalence of risk alleles in the background populations, but may also re¯ect haplotypic associations and/or yet uncharacterized susceptibility genes within the HLA gene region [16,30].…”
Section: Discussionmentioning
confidence: 99%
“…Standard dot-blot hybridization with digoxygeninlabelled oligonucleotide probes was used as a reference method [16]. Standard dot-blot hybridization with digoxygeninlabelled oligonucleotide probes was used as a reference method [16].…”
Section: Methodsmentioning
confidence: 99%
“…Likewise, susceptibility has also been linked to specific HLA-A and HLA-B Class I alleles (29), however little is known about the role of the disease-associated variants in T1D. However, it should be noted that when HLA-B*39 is combined in a HLA haplotype with DRB1*0404-DQB1*0302, patients are at significantly heightened risk (30). This is a demonstration of gene-gene interaction or epistasis, controlling T1D onset.…”
Section: Geneticsmentioning
confidence: 99%